US · Financial Services

Drugs Made In America Acquisition Corp. Units (DMAAU)

Shell Companies

Drugs Made In America Acquisition Corp. Units (DMAAU) is listed on US in the Financial Services sector. Industry: Shell Companies. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DMAAU

P/E ratio

18.00

Drugs Made In America Acquisition Corp. Units (DMAAU) — FAQ

What is DMAAU's P/E ratio?

The price-to-earnings (P/E) ratio for Drugs Made In America Acquisition Corp. Units (DMAAU) is 18.00 (data as of 2026-03-24).

Does Drugs Made In America Acquisition Corp. Units pay a dividend?

Dividend yield is not available in the current snapshot for Drugs Made In America Acquisition Corp. Units (DMAAU). Check the MyAverix Finance app for the latest dividend data.

What sector is Drugs Made In America Acquisition Corp. Units in?

Drugs Made In America Acquisition Corp. Units (DMAAU) is classified in the Financial Services sector (Shell Companies industry).

What exchange is DMAAU listed on?

DMAAU is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Financial Services companies

Administradora Americana de Inversiones S.A. (AAISA) Aflac Incorporated (A1FL34) Agricultural Bank Of China (1288) AIA Group Ltd (1299) American International Group, Inc. (AIGB34) Ameriprise Financial Inc. (A1MP34) Arthur J. Gallagher & Co. (A1JG34) Banco Santander S.A. (BSD2)